| 甲巯咪唑片引起重度粒细胞缺乏症1例并文献分析 |
| |
| 引用本文： | 邓小红,黄朝忠,刘振杰,罗强,李涛,侯时昭,徐宁.甲巯咪唑片引起重度粒细胞缺乏症1例并文献分析[J].国际医药卫生导报,2022,28(17):2447-2450. |
| |
| 作者姓名： | 邓小红 黄朝忠 刘振杰 罗强 李涛 侯时昭 徐宁 |
| |
| 作者单位： | 1广东省中医院 广州中医药大学第二附属医院检验医学部，广州 510006；
2广州中医药大学第二临床医学院，广州 510006；
3广东省中医院 广州中医药大学第二附属医院急诊科，广州 510006 |
| |
| 基金项目： | 广州民政科技基金（2021MZK24） |
| |
| 摘 要： | 目的 分析甲巯咪唑片致重度粒细胞缺乏症的一般规律和临床特点。方法 基于1例甲巯咪唑片致重度粒细胞缺乏症的病例，检索中国知网、万方数据库和Pubmed数据库建库至2022年2月公开发表的文献，分析甲巯咪唑致重度粒细胞缺乏症的一般规律及临床特点。结果 共纳入文献44篇，包含患者49例，其中男性7例（14.3%），女性42例（85.7%），年龄（39.3±15.5）岁，日剂量为（29.9±11.9）mg，重度粒细胞缺乏症多发生于用药后1～3个月内，常有高热、咽痛等症状，大部分患者经积极治疗可好转，但仍有部分患者因感染性休克、呼吸衰竭而死亡。结论 甲巯咪唑可导致罕见的重度粒细胞缺乏症，临床医生应注意合理用药，以减少和避免重度粒细胞缺乏症的发生。
|
| 关 键 词： | 甲巯咪唑片 不良反应 粒细胞缺乏症 甲状腺功能亢进症 |
| 收稿时间： | 2022-07-09 |
One case report and literature review of severe agranulocytosis induced
by methimazole tablets |
| |
| Deng Xiaohong,Hunag Chaozhong,Liu Zhenjie,Luo Qiang,Li Tao,Hou Shizhao,Xu Ning.One case report and literature review of severe agranulocytosis induced
by methimazole tablets[J].International Medicine & Health Guidance News,2022,28(17):2447-2450. |
| |
| Authors: | Deng Xiaohong Hunag Chaozhong Liu Zhenjie Luo Qiang Li Tao Hou Shizhao Xu Ning |
| |
| Abstract: | Objective To analyze the general rules and clinical characteristics of severe
agranulocytosis caused by methimazole tablets. Methods Based on a case of severe agranulocytosis caused by methimazole tablets,
the literatures on severe agranulocytosis caused by methimazole were collected
from the databases of CNKI, Wanfang, and PubMed from their establishment to
February 2022, and the general rules and clinical characteristics of which were
statistically analyzed. Results A total of 44
literatures were included. A total of 49 patients were enrolled in this study,
including 7 males (14.3%) and 42 females (85.7%), with age of (39.3±15.5) years
and an average daily dose of (29.9±11.9) mg. The severe agranulocytosis usually
occurred 1-3 months after medication and most patients were accompanied by high
fever and sore throat. The symptoms of most patients improved after treatment,
but some patients died of severe septic shock and respiratory failure. Conclusions Methimazole can cause
severe agranulocytosis. Clinicians should keep a close eye on rational use of
drugs so as to reduce and avoid severe agranulocytosis. |
| |
| Keywords: | Methimazole Adverse reactions Agranulocytosis Hyperthyroidism |
|
| 点击此处可从《国际医药卫生导报》浏览原始摘要信息 |
|
点击此处可从《国际医药卫生导报》下载全文 |
|
